The survival of patients received combined chemotherapy including ifosfamide(IFO)and platinum was longr than that of other patients, and the median survival was 24 months.

• 治疗方法以异环磷酰胺联合铂类化疗生存时间较长，中位生存时间为24个月。由于肿瘤再次复发造成肠梗阻而行肠断切除，或行肠胃吻合，或肠造瘘术的，不能延长生存期。